Janus Henderson Group PLC Sells 666,311 Shares of Bath & Body Works, Inc. $BBWI

Key Points

• Janus Henderson Group cut its Bath & Body Works stake by 87.3%, selling 666,311 shares in the first quarter and retaining 96,600 shares valued at approximately $1.8 million.
• Analyst sentiment remains cautious: the stock has a consensus “Hold” rating from MarketBeat, with an average price target of $21.93; institutional investors own 95.14% of the shares.
• Bath & Body Works reported quarterly EPS of $0.32, beating estimates, while revenue declined 3.2% year over year. The company also declared a quarterly dividend of $0.20 per share, representing a 3.9% annualized yield.

Janus Henderson Group PLC trimmed its stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 87.3% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 96,600 shares of the company's stock after selling 666,311 shares during the period. Janus Henderson Group PLC's holdings in Bath & Body Works were worth $1,803,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Geneos Wealth Management Inc. lifted its stake in shares of Bath & Body Works by 217.7% in the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company's stock valued at $35,000 after buying an additional 801 shares during the period. Danske Bank A S bought a new position in Bath & Body Works during the third quarter valued at about $39,000. Global Retirement Partners LLC bought a new position in Bath & Body Works during the fourth quarter valued at about $31,000. Activest Wealth Management acquired a new position in Bath & Body Works in the 4th quarter valued at approximately $32,000. Finally, Advisory Services Network LLC acquired a new position in Bath & Body Works in the 3rd quarter valued at approximately $48,000. Institutional investors own 95.14% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on BBWI. Morgan Stanley reissued an "equal weight" rating and set a $22.00 price objective on shares of Bath & Body Works in a report on Monday, July 6th. UBS Group reduced their target price on Bath & Body Works from $22.00 to $19.00 and set a "neutral" rating for the company in a research report on Wednesday, May 20th. Piper Sandler began coverage on shares of Bath & Body Works in a research note on Friday, May 15th. They set a "neutral" rating and a $20.00 price target on the stock. Barclays lowered their price target on shares of Bath & Body Works from $25.00 to $23.00 and set an "equal weight" rating on the stock in a report on Thursday, May 28th. Finally, TD Cowen increased their price objective on shares of Bath & Body Works from $20.00 to $25.00 and gave the company a "buy" rating in a research note on Thursday, May 28th. Three equities research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, Bath & Body Works presently has an average rating of "Hold" and a consensus target price of $21.93.

Bath & Body Works Trading Down 0.1%

NYSE BBWI opened at $20.34 on Monday. The firm has a market cap of $4.10 billion, a price-to-earnings ratio of 5.71, a PEG ratio of 2.01 and a beta of 1.38. The company has a 50 day moving average of $20.30 and a 200-day moving average of $20.27. Bath & Body Works, Inc. has a 1-year low of $14.27 and a 1-year high of $32.32.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its earnings results on Wednesday, May 27th. The company reported $0.32 EPS for the quarter, topping the consensus estimate of $0.29 by $0.03. The business had revenue of $1.38 billion for the quarter, compared to the consensus estimate of $1.36 billion. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.Bath & Body Works's revenue was down 3.2% compared to the same quarter last year. During the same period in the previous year, the business earned $0.49 EPS. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, analysts forecast that Bath & Body Works, Inc. will post 2.63 earnings per share for the current year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 4th. Shareholders of record on Friday, August 21st will be paid a $0.20 dividend. The ex-dividend date of this dividend is Friday, August 21st. This represents a $0.80 dividend on an annualized basis and a yield of 3.9%. Bath & Body Works's payout ratio is currently 22.47%.

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source